Don't miss

Replay


LATEST SHOWS

MEDIAWATCH

#ChooseFrance campaign aims to show 'France is back'

Read more

BUSINESS DAILY

Davos 2018: Balancing tech risks and opportunities

Read more

THE DEBATE

Erdogan's new front: Turkey takes on Syria's kurds (part 2)

Read more

THE DEBATE

Erdogan's new front: Turkey takes on Syria's kurds (part 1)

Read more

BUSINESS DAILY

Davos 2018: Modi defends globalisation but warns it's losing its lustre

Read more

FOCUS

Namibia's genocide: Descendants sue Germany for reparations

Read more

THE INTERVIEW

Ex-president Lula is 'clearly innocent', Rousseff says

Read more

ENCORE!

Author Mohsin Hamid: The magic of the migrant crisis

Read more

TALKING EUROPE

Estonia at 100: President Kaljulaid on risks, opportunities and Europhilia

Read more

Europe

Antiviral side effects may outweigh benefits for children

Video by FRANCE 24 , FRANCE 2 , Luke SHRAGO , Rachel MARUSAK

Text by NEWS WIRES

Latest update : 2009-08-11

Children should not routinely be given flu drugs like Tamiflu and Relenza to prevent A(H1N1) since there is no clear evidence that they prevent complications, British researchers say, adding that potential side effects may outweigh the benefits.

Reuters - Children should not routinely be given flu drugs like Tamiflu since there is no clear evidence they prevent complications and potentially harmful side effects may outweigh any benefits, British researchers said on Monday.

 

"While morbidity and mortality in the current pandemic remain low, a more conservative strategy might be considered prudent, given the limited data, side effects such as vomiting, and the potential for developing resistant strains of influenza," they said.

 

Governments around the world have built up stockpiles of Roche's Tamiflu and GlaxoSmithKline's Relenza to deal with the current H1N1 swine flu pandemic.

 

In Britain, hundreds of thousands of doses of Tamiflu have been handed out to people with the disease, of whom around half are children.

 

But Matthew Thompson from the University of Oxford and colleagues reported in the British Medical Journal that while antivirals shortened the duration of flu in children by around a day, they didn't reduce asthma flare-ups or the likelihood of children needing antibiotics.

 

Tamiflu was also linked to an increased risk of vomiting, which can be serious in children.

 

The analysis was based on a systematic review of seven previous clinical studies looking at use of Tamiflu and Relenza in seasonal flu outbreaks in children aged 1 to 12 years.

 

Thompson told reporters there was no reason to think the conclusions would not also apply to the current relatively mild outbreak of swine flu.

 

Date created : 2009-08-10

COMMENT(S)